CD274 and cancer: The negative correlation with CD274 (PD-L1), a key immune checkpoint molecule involved in cancer immune evasion, suggests that higher PIGF expression may be associated with lower PD-L1 levels in HNSCC, potentially reducing immune suppression (Mann et al., 2023; Boschert et al., 2020).